From: The metabolic syndrome and progression of carotid atherosclerosis over 13 years. The Tromsø study
Follow-up levels | Change from baseline to follow-up | |||||||
---|---|---|---|---|---|---|---|---|
IMT (mm) | TPA†(mm²) | ΔIMT (mm) | ΔTPA†(mm²) | |||||
β | p‡ | β | p‡ | β | p‡ | β | p‡ | |
Men | ||||||||
Metabolic syndrome | 0.051 | 0.0003 | 0.372 | 0.009 | - | - | - | - |
Age | 0.008 | <0.0001 | 0.074 | <0.001 | - | - | 0.031 | <0.0001 |
LDL cholesterol | 0.016 | 0.004 | 0.232 | <0.001 | - | - | - | - |
Daily smoking | 0.038 | 0.002 | 0.564 | <0.001 | - | - | 0.514 | 0.001 |
Women | ||||||||
Metabolic syndrome | 0.045 | 0.0004 | - | - | - | - | - | - |
Age | 0.008 | <0.0001 | 0.049 | <0.0001 | 0.002 | <0.0001 | 0.031 | <0.0001 |
LDL cholesterol | 0.022 | <0.0001 | 0.227 | <0.0001 | - | - | 0.204 | 0.0002 |
Daily smoking | - | - | 0.503 | <0.0001 | 0.033 | 0.001 | 0.498 | 0.0002 |